Robert Karr

Directeur Général chez Drosmed LLC

Profil

Robert W.
Karr is the founder of Euclises Pharmaceuticals, Inc. (2011).
Dr. Karr is also the founder of Indalo Therapeutics, Inc. Dr. Karr is currently the Executive Chairman & Chief Executive Officer at Cadre Bioscience LLC since 2019, President & Chief Executive Officer at Drosmed LLC, President & Director at Myonid Therapeutics Inc., and Managing Member at Startup Partners International LLC since 2010.
Former positions include Chief Executive Officer at Zevra Therapeutics, Inc., President, Chief Executive Officer & Director at Arch Oncology, Inc. (2015-2016), Independent Director at Idera Pharmaceuticals, Inc. (2005-2015), Independent Director at GTx, Inc. (2011), Non-Executive Director at Verseon Corp.
(2017-2018), Director at Tansna Therapeutics, Inc., Managing Director at Karr Pharma Consulting LLC, Director at Antegrin Therapeutics LLC, Senior Executive-Global Research & Development at Pfizer Inc. (2004), Vice President-Research & Development Strategy at Warner-Lambert Co., Principal at G.D.
Searle & Co., Inc. (1999), Faculty Member at the University of Iowa, Principal at Idera, Inc., Member at Startup Midwest Management LLC (2010), and Faculty Member at Washington University School of Medicine.
Education includes an undergraduate degree from Southwestern University (1971) and a doctorate from the University of Texas Medical Branch (1975).

Postes actifs de Robert Karr

Sociétés	Poste	Début
Drosmed LLC	Directeur Général	-
Startup Partners International LLC	Corporate Officer/Principal	01/01/2010
Cadre Bioscience LLC	Directeur Général	01/12/2019
Myonid Therapeutics Inc.	President	-

Anciens postes connus de Robert Karr

Sociétés	Poste	Fin
VERSEON CORP	Directeur/Membre du Conseil	05/11/2018
Idera Pharmaceuticals, Inc.	Directeur/Membre du Conseil	08/06/2015
GTx, Inc.	Directeur/Membre du Conseil	05/05/2011
Startup Midwest Management LLC	Corporate Officer/Principal	01/02/2010
PFIZER INC.	Directeur Technique/Scientifique/R&D	01/12/2004